Levy Wealth Management Group, LLC Seagen Inc. Transaction History

Levy Wealth Management Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$187.64 - $206.25 $45,971 - $50,531	245 Added 10.08%	2,675 $514,000
Q3 2021 Oct 26, 2021	SELL	$142.45 - $169.82 $4,273 - $5,094	-30 Reduced 1.22%	2,430 $413,000
Q4 2020 Feb 10, 2021	BUY	$164.63 - $211.93 $404,989 - $521,347	2,460 New	2,460 $431,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Levy Wealth Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Levy Wealth Management Group, LLC with notifications on news.